Home › Pharmacology › Beta-Lactamase Inhibitor Penicillins

Beta-Lactamase Inhibitor Penicillins

For medical students2 min readUpdated 2026-10-10

Beta-lactamase inhibitor penicillins are combinations of semi-synthetic penicillins and specialized agents that block bacterial protective enzymes. This approach successfully overcomes microbial resistance and broadens the antimicrobial spectrum of therapy.

InhibitorsClavulanic acid, sulbactam, tazobactam

Target of ProtectionInhibition of bacterial beta-lactamases

CombinationsAmoxicillin/clavulanate, ampicillin/sulbactam, piperacillin/tazobactam, ticarcillin/clavulanate

GI RisksPseudomembranous colitis possible

Resistance Problem and Mechanism of Protection

Standard broad-spectrum semi-synthetic penicillins are vulnerable to bacterial defense mechanisms. Microorganisms produce specialized enzymes called beta-lactamases (penicillinases) that effectively hydrolyze and destroy the antibiotic before it can exert its therapeutic effect.

To overcome this issue, combination drugs have been developed. They consist of the antibiotic itself combined with a beta-lactamase inhibitor. The inhibitors possess weak intrinsic antibacterial properties and share a structural similarity—they also contain a beta-lactam ring. Upon entering the body, they bind to bacterial enzymes and irreversibly inactivate them, protecting the primary antibiotic from hydrolysis.

Expansion of the Antimicrobial Spectrum

Protected from enzymatic degradation, these combination drugs are effective against microorganisms capable of producing beta-lactamases. Their spectrum of activity covers:

Gram-negative and Gram-positive bacteria: Staphylococcus species, Klebsiella, Haemophilus influenzae, Moraxella, Shigella, and Salmonella.
Anaerobic microorganisms, particularly the Bacteroides fragilis group.

Key Combination Drugs

In modern medical practice, several fixed combinations of antibiotics and inhibitors are used:

Amoxicillin + clavulanic acid (known as amoxicillin/clavulanate or augmentin).
Ampicillin + sulbactam (unasyn).
Piperacillin + tazobactam (zosyn) — this combination has the broadest spectrum of antimicrobial activity.
Ticarcillin + clavulanic acid (timentin).

Adverse Reactions and Side Effects

The use of these drugs is associated with several potential complications:

Allergic reactions: ranging from skin rash, urticaria, and bronchospasm to angioedema and anaphylactic shock. The pathogenesis involves the metabolism of the drug into penicilloic acid. It binds to body proteins, forming a "hapten-carrier" complex that acquires foreign immunogenic properties.
Gastrointestinal tract: dyspepsia (nausea, vomiting, abdominal pain, diarrhea), as well as a severe and life-threatening complication—pseudomembranous colitis.
Local reactions: pain and infiltrates at intramuscular injection sites, and phlebitis with intravenous administration.
Superinfection: development of vaginal candidiasis or oral candidiasis.

Frequently asked questions

What dosages and administration regimens are used for amoxicillin/clavulanate?

Dosages and regimens for amoxicillin/clavulanate depend on the patient's age and clinical indications. For oral administration, the following regimens are used:

Adults and children over 12 years weighing more than 40 kg — 875/125 mg every 12 hours.
Children from 3 months to 12 years — 90 mg/kg/day of amoxicillin component, divided into 2 doses every 12 hours.
Children under 3 months — 30 mg/kg/day of amoxicillin, divided into 2 doses every 12 hours.

In tuberculosis therapy, carbapenems are used only in conjunction with amoxicillin/clavulanate. For adults, a dose of 1000/250 mg daily is indicated; calculations are often based on the clavulanate component — 125 mg every 8–12 hours.

What absolute and relative contraindications exist for prescribing piperacillin/tazobactam?

Contraindications for prescribing piperacillin/tazobactam are generally limited by age parameters. The drug is contraindicated in early infancy. Depending on specific clinical treatment protocols for conditions like cystic fibrosis, age restrictions may apply to patients under 3 months or under 2 years of age. No other absolute or relative contraindications are highlighted.

Which medications are pharmaceutically incompatible with penicillins in the same syringe or infusion set?

Penicillins are pharmaceutically incompatible in the same syringe or infusion system with aminoglycosides and acetylcysteine.

Aminoglycosides — carry a positive charge, whereas penicillins are negatively charged. Mixing them causes a physicochemical interaction resulting in an inactive complex and precipitation, rendering the drugs ineffective.
Acetylcysteine — mixing in the same syringe or solution with any antibiotic leads to inactivation of the drug.

What enzymes destroy conventional penicillins and how are they combated?

Conventional penicillins are destroyed by bacterial enzymes known as beta-lactamases. The solution involves adding inhibitors (clavulanic acid, sulbactam, tazobactam) that irreversibly bind these enzymes and protect the antibiotic.

Why are beta-lactamase inhibitor penicillins active against anaerobes?

Their antimicrobial spectrum includes anaerobic bacteria, particularly members of the Bacteroides fragilis group, due to the synergistic action of the protected antibiotic.

Which drug in this group has the broadest spectrum of activity?

The combination of piperacillin with tazobactam (zosyn) exhibits the broadest spectrum of antimicrobial activity.

Go deeper

Mechanism of "hapten-carrier" complex formation in penicillin allergy
Comparative characteristics of sulbactam, tazobactam, and clavulanic acid
Clinical differences between augmentin and unasyn
Diagnosis and management principles of pseudomembranous colitis
Features of superinfection development during antibiotic therapy